Decreased T-cell proliferative response to common environmental antigens could be an indicator of early human immunodeficiency virus-mediated lymphocyte lesions

To evaluate CD4+/CD29+ cells and their responses to different antigens in polar stages of human immunodeficiency virus (HIV) infection, we studied 26 HIV-seropositive carriers (SPCs) and 15 patients with AIDS simultaneously with 20 healthy volunteers (HVs) and 10 seronegative homosexual and bisexual men (SNH). CD3, CD4, CD29, and CD45RA phenotypes were analyzed by two-color flow cytometry. Significant depletion of CD4+ T cells and both memory (CD4+/CD29+) and naive (CD4+/CD45RA+) T-cell subsets was found among SPCs and AIDS patients compared with the numbers of such cells in the HV and SNH groups. Responses to optimal doses of Candida albicans, streptokinase, and tetanus toxoid were explored in peripheral blood mononuclear cells and CD4(+)- and CD4+/CD29(+)-enriched cell populations. In SPCs, the response to C. albicans in peripheral blood mononuclear cells showed a statistically significant diminution compared with the response of HVs (15,308 versus 35,951 cpm). In addition, a significantly reduced response to streptokinase was evident only when cell preparations were CD4+/CD29+ enriched (3,048 versus 10,367 cpm). Furthermore, the SPC group comprised seven responders to at least one antigen and seven nonresponders to any of the selected specific antigens. Absence of a response in these latter patients was independent of the absolute counts of memory and naive T-cell populations. The response to tetanus toxoid, although diminished in SPCs, was not significantly different from that in controls. Our results suggest that defective responses to common environmental antigens, unrelated to the absolute number of CD4+/CD29+ cells, is probably an early indicator of an HIV-induced lymphocyte lesion.

[1]  D. Scott‐Algara,et al.  Differential requirements for HIV‐1 replication in naive and memory CD4 T cells from asymptomatic HIV‐1 seropositive carriers and AIDS patients , 1993, Clinical and experimental immunology.

[2]  N. Bianco.  The immunopathology of systemic anergy in infectious diseases: a reappraisal and new perspectives. , 1992, Clinical immunology and immunopathology.

[3]  M. Clerici,et al.  Multiple patterns of alloantigen presenting/stimulating cell dysfunction in patients with AIDS. , 1991, Journal of immunology.

[4]  J. Justement,et al.  Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[5]  F. Miedema,et al.  Selective loss of T cell functions in different stages of HIV infection Early loss ofanti‐CD3‐induced T cell proliferation followed by decreased anti‐CD3‐induced cytotoxic T lymphocyte generation in AIDS‐related complex and AIDS , 1990, European journal of immunology.

[6]  I. Blanca,et al.  [Immunopathogenic aspects of infection by the human immunodeficiency virus in Venezuela]. , 1988, Boletin de la Oficina Sanitaria Panamericana. Pan American Sanitary Bureau.

[7]  D. Boone,et al.  Peripheral blood mononuclear cell abnormalities and their relationship to clinical course in homosexual men with HIV infection. , 1988, Clinical immunology and immunopathology.

[8]  F. Vuillier,et al.  Comparative analysis of CD4-4B4 and CD4-2H4 lymphocyte subpopulations in HIV negative homosexual, HIV seropositive and healthy subjects. , 1988, Clinical and experimental immunology.

[9]  Fauci As.  AIDS: immunopathogenic mechanisms and research strategies. , 1987 .

[10]  J V Giorgi,et al.  Early effects of HIV on CD4 lymphocytes in vivo. , 1987, Journal of immunology.

[11]  A. Fauci.  AIDS: immunopathogenic mechanisms and research strategies. , 1987, Clinical research.

[12]  R. Redfield,et al.  A model for the selective loss of major histocompatibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS). , 1986, Journal of immunology.

[13]  R. Redfield,et al.  Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. , 1986, MMWR. Morbidity and mortality weekly report.

[14]  A. Fauci,et al.  Immunopathogenesis of the acquired immunodeficiency syndrome. , 1986, Annals of internal medicine.

[15]  T. Waldmann,et al.  Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition. , 1985, The New England journal of medicine.

[16]  N. Letvin,et al.  The isolation and characterization of the human helper inducer T cell subset. , 1985, Journal of immunology.

[17]  N. Letvin,et al.  The isolation and characterization of the human suppressor inducer T cell subset. , 1985, Journal of immunology.

[18]  L. Wysocki,et al.  "Panning" for lymphocytes: a method for cell selection. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Elizabeth Simpson,et al.  A rapid method for the isolation of functional thymus‐derived murine lymphocytes , 1973, European journal of immunology.